Impotence Spray Sex Aid
Written by Stuart Stevens | Friday, 03 March 2006 | There are 6 comments
Viagra, Cialis and Levitra are now commonly known erectile dyfunction drugs, however there is now a new drug undergoing testing that be bo sold soon. It is different from the others in that it can be used by males and females. This sex aid is also original in that it comes as a nasal spray and not as the usual tablets. Reserachers say that lack of sexual desire and erectile function difficulties are apparent in all societies.
The new nasal spray despite the fact that it needs to be fully tested and researched is getting good feedback from participants. Until it gains a commercial name its manufacturers are calling it PT-141.
The advantage of a nasal spray is the fact that it begins to work straight away. The makers of the drug say that it is ideal for those couples who only warrant a small boost in the bedroom rather than those who have serious erectile dysfunction problems due to health or physcological reasons. The nasal sex spray could be a very popular drug and catch on very fast if the testing proves to be successful.
PT-141 has reached the 3rd phase of tests and on the completion of these procedures the drug will be evaluated by the FDA for licencing and final approval. Due to rigorous testing procedures in the USA the product is unlikely to be on sale for 2 years and will only be available with prescription. PT-141 may become known as the gentler form of Viagra.

There are 6 comments on this article.
marco soares said:
kool
James said:
When will it come on the market or get approved. I have been hearing about this drug for 2 yrs. Get on with it
Paula said:
do you think I could spray it up my husband's nose when he is asleep!!!!!?????
jas said:
where can i buy this spray
Josie said:
Paula that is exactly what I was thinking!!! Ukmedix are you going to have this available for us?
The Ukmedix Dude said:
It still needs more testing before it will get approval. Testing has showed that if you inhale it you might get high blood pressure. Probably needs another 2years of clinical trials.
Fields marked with * are required.

